New fNIR Technology Sheds Light on Brain Activity with Powerful Imagers for Real-world Situations
Systems offer comfort and mobility to measure human subjects in the lab, at home, or in the real world
GOLETA, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) -- BIOPAC Systems, Inc., the global distributor for fNIR Devices, announced the availability of its newest generation of functional near infrared optical imaging (fNIR) systems. The new high-density imaging systems provide in-lab or real-world cognitive function assessments for physiology researchers looking to understand brain activity without all the expense of fMRI.
The extra-lightweight sensor fits comfortably on the forehead where it monitors relative changes in oxy or deoxy hemoglobin as a proxy for the brain activity in the pre-frontal cortex. Subjects can be examined in laboratory settings or they can be active in their natural environment with the new mobile fNIR system.
The new NIRS systems offer three powerful imagers. The fNIR 2000C is a stationary unit that collects data from up to 18 optodes. The fNIR 2000M is a wireless and mobile imager that collects data from up to 18 optodes and can be used while subjects are performing tasks in the lab or in the real world. The fNIR 2000S is a 54-optode capable imager with advanced features for recording up to three subjects simultaneously.
A new through-the-hair sensor will allow researchers to assess other areas of the brain such as motor and visual cortices. Adding in different parts of the brain increases understanding of brain activity without the complications of fMRI.
All systems include fNIRSoft and COBI software for data collection and analysis. Data can be synchronized with and imported into AcqKnowledge Software for a complete understanding of physiological response, including EEG, EDA, ECG, BP, and other important physiology signals.
“Experimental design can be more sophisticated with this mobile technology. It gives researchers the opportunity to collect data from subjects as they live their lives.” said Frazer Findlay, BIOPAC’s CEO. “Mobile imaging can add value to any study but is especially important when subjects are children or families, as they can be in a familiar or comfortable environment, yielding better results.”
“When designing and manufacturing fNIR Devices, we decided not to weigh down the subject’s head with a battery and extra electronics. As a result, our imagers, including our wireless imager, measure the brain’s hemodynamic response with minimal weight and maximum comfort.” said Davood Tashayyod, fNIR Devices CEO. “fNIR Devices systems are very easy to set up and very comfortable for the subject. A comfortable subject produces better quality data and can participate in short- and long-term studies.”
fNIR and NIR imaging are citied in over 132,000 publications. NIR applications include Brain Computer Interface, Human Performance Assessment, Neurorehabilitation, Depth of Anesthesia Monitoring, and more. fNIR technology can also be used to understand blood oxygenation of muscles.
Contact BIOPAC for more information about using fNIR technology for measuring mobile subjects in real-world situations, stationary subjects in a lab, or when teaching students in an educational environment.
About BIOPAC Systems
BIOPAC was founded in 1985 and is recognized around the world as a premier choice for life science hardware and software. Worldwide, over 99% of the top 100 universities and Global Fortune 500 companies rely on BIOPAC systems for their life science research and teaching system needs. BIOPAC makes high-quality scientific tools for physiology measurement and interpretation. BIOPAC solutions range from educational solutions to cutting-edge devices for use in lab, real world, and virtual reality research environments. For more information on BIOPAC products, visit www.biopac.com.
About fNIR Devices
Founded in 2009, fNIR Devices, LLC, is the premier supplier of Continuous Wave Functional Near Infrared (fNIR) Spectroscopy imaging systems for research and other non-clinical applications. fNIR Devices provide physiology researchers with robust and meticulously crafted systems for monitoring the brain’s hemodynamics, thereby understanding the subject’s cognitive state in both lab and natural environments.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/ea24834a-8a45-4d6c-a5d8-46271fa5f249
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Bombardier’s Multi-Award-Winning Global 7500 Jet Reaches New Heights in the Heart of the Swiss Alps15.7.2019 19:00:00 CEST | Press release
Global 7500 aircraft is the most spacious purpose-built business jet to operate out of Gstaad’s Saanen airport in Switzerland, where it was on display earlier this month before flying to Dubai, performing another exceptional long-range mission Mission highlights the Global family’s advanced wing design, which enables them to access challenging airfields with short runways in hot temperatures and/or high altitude locations, giving passengers direct access to the heart of the Swiss Alps all year round The Aviation Week Grand Laureate Global 7500 aircraft, also recently recognized as Business Jet of the Year in Robb Report’s Best of the Best 2019, offers Bombardier’s signature smooth ride and a spaciousness that is unique among business jets Bombardier’s Challenger 350 aircraft, also recognized as the Best of the Best Super Mid-size Aircraft by Robb Report, joined the Global 7500 jet on display in Gstaad and achieved a speed record, reaching Malaga in 2 hours and 4 minutes MONTREAL, July
Brookfield Asset Management 2019 Second Quarter Results Conference Call and Webcast15.7.2019 18:27:00 CEST | Press release
Date: Thursday, August 8, 2019 Time: 11:00 a.m. (Eastern Time) BROOKFIELD, NEWS, July 15, 2019 (GLOBE NEWSWIRE) -- Brookfield Asset Management (NYSE:BAM)(TSX:BAM.A)(EURONEXT AMSTERDAM:BAMA): Second Quarter Conference Call You are invited to participate in Brookfield Asset Management’s 2019 Second Quarter Conference Call & Webcast on Thursday, August 8, 2019 at 11:00 a.m. (Eastern Time) to discuss with members of senior management our results and current business initiatives. These results will be released on August 8th before 7:00 a.m. (Eastern Time) and will be available following the release on our website at www.brookfield.com “News – Press Releases.” The Conference Call will also be Webcast live on our website, where it will be archived for future reference. To participate in the Conference Call, please dial 1-866-688-9425 toll free in North America, or for overseas calls please dial 1-409-216-0815 (Conference ID: 8258617) at approximately 10:50 a.m. The Conference Call will also b
Virtusa Achieves AWS Life Sciences Competency Status15.7.2019 16:01:00 CEST | Press release
Virtusa joins a group of AWS Partner Network members helping Life Sciences providers to deliver superior patient outcomes SOUTHBOROUGH, Mass., July 15, 2019 (GLOBE NEWSWIRE) -- Virtusa Corporation (NASDAQ GS: VRTU), a global provider of digital strategy, digital engineering, and IT outsourcing services that accelerates business outcomes for its clients, announced today that it has achieved Amazon Web Services (AWS) Life Sciences Competency status. This designation recognizes Virtusa for providing deep expertise in building Life Sciences solutions on AWS to help customers conduct drug discovery, manage clinical trials, engage in manufacturing and distribution activities, conduct research and development of novel genetic-based treatments and companion diagnostics. Achieving the AWS Life Sciences Competency differentiates Virtusa as an AWS Partner Network (APN) member that has demonstrated relevant technical proficiency and proven customer success, delivering solutions seamlessly on AWS.
LGC Capital, Ltd., announces Trichomed received its cultivation license from Health Canada for its new cannabis facility in Brownsburg, Quebec15.7.2019 15:28:00 CEST | Press release
MONTREAL, July 15, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSX-V: LG / OTCQB: LGGCF) LGC Capital Ltd. (“LGC” or the “Company”), announces that Health Canada, on July 12th, awarded Trichomed Corporation (Trichomed), its long awaited license to cultivate cannabis seeds and plants at its newly constructed facility in Brownsburg, Quebec. As per the terms of its agreement with Trichomed, LGC is, now entitled to convert the first ranking secured loan it provided to Trichomed in December 2017 into a 49% direct equity interest, and a five percent (5%) royalty of Trichomed’s net sales of cannabis and cannabis-related prodcuts which covers actual sales less any arm’s length third-party discounts, merchandise returns and rebates. In addition as per the agreement, LGC is entitled to representation on Trichomed’s board. For further information, please contact: John McMullen, President Tel: (416) 803-0698 email@example.com Mark Shinners, Chief Financial Officer Tel: +44 7827 960971 mark@lgc-ca
WillScot to Participate at the Jefferies Industrials Conference15.7.2019 15:00:00 CEST | Press release
BALTIMORE, July 15, 2019 (GLOBE NEWSWIRE) -- WillScot Corporation (“WillScot”) (Nasdaq: WSC), the specialty rental services market leader providing innovative modular space and portable storage solutions across North America, today announced that Brad Soultz, President and Chief Executive Officer, and Tim Boswell, Chief Financial Officer, will present at the Jefferies Industrials Conference in New York, on Wednesday, August 7, 2019. The presentation will take place at 11:30 a.m. EDT. About WillScot Corporation Headquartered in Baltimore, Maryland, WillScot is the public holding company for the Williams Scotsman family of companies. WillScot trades on the Nasdaq stock exchange under the ticker symbol "WSC," and is the specialty rental services market leader providing innovative modular space and portable storage solutions across North America. WillScot is the modular space supplier of choice for the construction, education, health care, government, retail, commercial, transportation, se
WSO2 Introduces WSO2 API Microgateway 3.0 to Simplify Creating, Deploying and Securing APIs in Microservice Environments15.7.2019 15:00:00 CEST | Press release
Newest release of the fully open source, cloud-native WSO2 API Microgateway adds new features to facilitate development and management while enabling greater scalability Mountain View, CA and Portland, OR, July 15, 2019 (GLOBE NEWSWIRE) -- Microservices are rapidly becoming the de facto standard for modern software development. As a result, thousands of microservices are replacing hundreds of enterprise apps within an organization—driving exponential growth in the number of programmable endpoints handled by APIs. To simplify the process of creating, deploying and securing APIs within distributed microservices architectures, WSO2 has introduced several new features in version 3.0 of its fully open source WSO2 API Microgateway. The availability of WSO2 API Microgateway 3.0 is being announced in conjunction with OSCON 2019, the O’Reilly Open Source Software Conference. WSO2, the world’s #1 open source integration vendor and an OSCON sponsor, will offer demos of the latest WSO2 API Microga